¼±Åà - È­»ìǥŰ/¿£ÅÍŰ ´Ý±â - ESC

 
"focal nodular hyperplasia"¿¡ ´ëÇÑ °Ë»ö °á°úÀÔ´Ï´Ù. °Ë»ö °á°ú º¸´Â µµÁß¿¡ Tab ۸¦ ´©¸£½Ã¸é °Ë»ö âÀÌ ¼±Åõ˴ϴÙ.
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
  • nodular goiter
    °áÀý°©»ó»ùÁ¾
  • nodular hidradenoma
    °áÀý¶¡»ùÁ¾
  • nodular leprosy
    °áÀý³ªº´
  • nodular panniculitis
    °áÀýÁö¹æÃþ¿°
  • nodular prurigo
    °áÀý°¡·Á¿ò¹ßÁø
  • nodular salpingitis
    °áÀýÀڱðü¿°, °áÀý³­°ü¿°
  • nodular scabies
    °áÀý¿È
  • nodular scleritis
    °áÀý°ø¸·¿°
  • nodular sclerosis
    °áÀý°æÈ­
  • primary pigmented nodular adrenocortical disease
    ¿ø¹ß»ö¼ÒÄ§Âø°áÀýºÎ½Å°ÑÁúº´, ¿ø¹ß»ö¼ÒÄ§Âø°áÀýºÎ½ÅÇÇÁúº´
  • subepidermal nodular fibrosis
    Ç¥ÇǹذáÀý¼¶À¯Áõ
  • systemic nodular panniculitis
    Àü½Å°áÀýÁö¹æÃþ¿°
  • angiolymphoid hyperplasia
    Ç÷°ü¸²ÇÁ±¸°ú´ÙÇü¼º, Ç÷°ü¸²ÇÁ±¸Áõ½Ä
  • atypical adenomatous hyperplasia
    ºñÁ¤Çü»ùÁ¾Áõ½Ä
  • atypical complex hyperplasia
    ºñÁ¤Çüº¹ÇÕÀڱ󻸷Áõ½Ä
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
  • nodular gliosis
    °áÀý½Å°æ¾Æ±³Áõ
  • nodular glomerulosclerosis
    °áÀýÅ丮±»À½Áõ, °áÀý»ç±¸Ã¼°æÈ­Áõ
  • nodular goiter
    °áÀý°©»ó»ùÁ¾, °áÀý¹æÆÐ»ùÁ¾
  • nodular hidradenoma
    (¢¡clear cell hidradenoma) Åõ¸í¼¼Æ÷¶¡»ùÁ¾
  • nodular leprosy
    °áÀý³ªº´
  • nodular lymphosarcoma
    °áÀý¸²ÇÁÀ°Á¾
  • nodular myolysis
    °áÀý±ÙÀ°¿ëÇØ
  • nodular panniculitis
    °áÀýÁö¹æÃþ¿°
  • nodular prurigo
    °áÀý°¡·Á¿ò¹ßÁø
  • nodular salpingitis
    °áÀýÀڱðü¿°
  • nodular scabies
    °áÀý¿È
  • nodular scleritis
    °áÀý°ø¸·¿°
  • nodular sclerosis
    °áÀý°æÈ­Áõ
  • nodular syphilid
    °áÀý¸Åµ¶Áø
  • nodular fat necrosis
    °áÀýÁö¹æ±«»ç
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 3 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
  • hyperplasia of adrenal gland
    ºÎ½Å¼±Áõ½Ä
  • hyperplasia,atypical
    ºñÁ¤Çü(ÞªïÒû¡)
  • hyperplasia,compensatory
    ´ë»ó¼º
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
  • focal point
    ÃÊÁ¡
  • focal segmental glomerulonephritis
    ÃÊÁ¡¼º ºÐÀý(¼º) »ç±¸Ã¼½Å¿°
  • focal segmental glomerulosclerosis; FSGS
    ±¹¼Ò¼ººÐÀý¼º»ç±¸Ã¼°æÈ­(Áõ)
  • focal spot
    ±¹¼Ò ÃÊÁ¡
  • focal spot
    ÃÊÁ¡
  • focal zone
    ÃÊÁ¡ ¿µ¿ª
  • glomerulonephritis,focal embolic
    ÃÊÁ¡¼º »öÀü¼º
  • glomerulonephritis,focal proliferative
    ÃÊÁ¡¼º Áõ½Ä¼º
  • glomerulosclerosis,focal segmental
    ÃÊÁ¡¼º ºÐÀý¼º
  • infection, oral focal
    ±¸°­º´¼Ò°¨¿°
  • infection, tonsillar focal
    Æíµµº´¼Ò°¨¿°
  • linear focal elastosis
    ¼±»ó±¹¼Òź·Â¼¶À¯Áõ
  • oral focal infection
    ±¸°­º´¼Ò°¨¿°
  • oral focal infection
    ±¸°­º´¼Ò°¨¿°(Ϣ˷ܻᵠÊïæø).
  • posterior focal line
    ÈÄÃʼ±(ý­õ¥àÊ).
KMLE ÀÇÇоà¾î »çÀü À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 3
CRNF chronic rheumatoid nodular fibrositis
MCN maternal child nursing; minimal change nephropathy; mixed cell nodular [lymphoma]
NAP nasion, point A, pogonion [convexity or concavity of the facial profile]; nerve action potential; ne...
N&D nodular and diffuse
NHL nodular histiocytic lymphoma; non-Hodgkin lymphoma
KMLE ÀÚµ¿ÃßÃâ ÀÇÇоà¾î »çÀü À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 3
PN papillary or nodular
FAK Focal Adhesion Kinase
FDH Focal Dermal Hypoplasia
FSGS Focal Segmental Glomerulosclerosis
FA focal adhesion
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°­³»°ú ±³½Ç »çÀü À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
    ¼³¸í
  • focal epilepsy
    ±¹¼Ò °£Áú, ÃÊÁ¡ °£Áú, ¿îµ¿ ÁßÃß ¼Õ»ó¼º °£Áú
  • focal epithelial
    ±¹¼Ò¼º »óÇÇ
  • focal glomerulonephritis
    ÃÊÁ¡¼º »ç±¸Ã¼ ½Å¿°
  • focal infection
    ÃÊÁ¡ °¨¿°
  • focal length
    ÃÊÁ¡ °Å¸®
    Áý±¤ ·»Áî·ÎºÎÅÍ ÃÖ´ë ÃÊÁ¡ À§Ä¡±îÁöÀÇ °Å¸®.
  • focal myelitis
    ¼Ò»ó ô¼ö¿°
  • focal oral mucitis
    ±¹¼Ò¼º ±¸°­ Á¡¾×Áõ
  • focal plane
    ÃÊÁ¡ ´Ü¸é
  • focal point
    ÃÊÁ¡
    ºûÀÌ Áý±¤ ·»Á ÅëÇØ Áö³ª°¥ ¶§ ±¤¼ÓÀÌ ÃÖ´ëÇÑ ³óÃàµÈ À§Ä¡.
  • focal proliferative glomerulonephritis
    ÃÊÁ¡¼º Áõ½Ä¼º »ç±¸Ã¼ ½Å¿°
  • focal seizure
    ±¹¼Ò °£Áú
  • focal spot
    ÃÐÁ¡
  • focal trough
    »óÃþ
  • hyperplasia
    ºñÈÄ, Áõ½Ä, °úÇü¼º
    1. ±â´É Ç×ÁøÀ» À¯¹ß½ÃŰ´Â ÀÚ±ØÀ» ¹Þ¾ÒÀ» ¶§, ºÐ¿­ÀÌ °¡´ÉÇÑ ¼¼Æ÷°¡ ¼¼Æ÷ ºÐ¿­·Î ±× ¼ö°¡ Áõ°¡µÇ´Â °ÍÀ» ¸»Çϸç, °á°úÀûÀ¸·Î ±× Á¶Á÷À̳ª Àå±âµµ Ä¿Áö°Ô µÈ´Ù. ¹Ý¸é, ºñ´ë´Â ¼¼Æ÷ÀÇ Áõ½ÄÀÌ ¾øÀÌ ´Ü¼øÈ÷ ¼¼Æ÷ÀÇ Å©±â°¡ Ä¿Áö´Â °æ¿ì¸¦ À̸£´Â ¸»ÀÌ´Ù. 2. Á¤»ó ¼¼Æ÷ ¼ö°¡ Á¤»óÀûÀÎ ¹è¿­ »óÅ·ΠÁõ°¡ÇÏ´Â Á¶Á÷À̳ª ±¸Á¶¹°ÀÇ °ú¹ßÀ°.
  • hyperplasia of coronoid
    ±Ùµ¹±â °úÁõ½Ä
CancerWEB ¿µ¿µ ÀÇÇлçÀü À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 3
nodular vasculitis Chronic or recurrent nodular lesions of subcutaneous tissue, especially of the legs of older women, with lobular panniculitis, granulomatous inflammation with multinucleated giant cells, focal necrosis, and obliterative inflammation of the small blood vessels, resembling erythema induratum but without evidence of associated tuberculosis.
(05 Mar 2000)
toxic nodular goitre <endocrinology> An enlarged thyroid gland which contains nodules which release excess thyroid hormone. This condition usually arises from long-standing simple goitre in the elderly.
Symptoms of hyperthyroidism result.
(12 Jan 1998)
localised nodular tenosynovitis A nodule, possibly inflammatory in nature, arising commonly from the flexor sheath of the fingers and thumb; composed of fibrous tissue, lipid-and haemosiderin-containing macrophages, and multinucleated giant cells.
Synonym: localised nodular tenosynovitis.
(05 Mar 2000)
adrenal hyperplasia <pathology> A condition of diffuse enlargement of the adrenal glands.
Origin: Gr. Plassein = to form
(27 Sep 1997)
adrenal hyperplasia, congenital A group of inherited disorders of adrenal steroidogenesis, the physical expression of which varies with the sex of the patient, the severity of the congenital enzyme defect, and the age at which the defect makes its presence felt. The most common form, the simple virilizing form, is due to a 21-hydroxylase deficiency. There is also a salt-losing form (a more complete 21-hydroxylase deficiency), a hypertensive form (11-hydroxylase deficiency), a 17-hydroxylase deficiency form, a desmolase deficiency form, and a 3-beta-hydroxysteroid deficiency form.
(12 Dec 1998)
angiofollicular mediastinal lymph node hyperplasia Solitary masses of lymphoid tissue containing concentric perivascular aggregates of lymphocytes, occurring usually in the mediastinum or hilar region of young adults; similar changes have been reported outside the mediastinum and, if associated with interfollicular sheets of plasma cells, may progress to lymphoma or plasmacytoma.
Synonym: angiofollicular mediastinal lymph node hyperplasia, Castleman's disease.
(05 Mar 2000)
angiolymphoid hyperplasia with eosinophilia Solitary or multiple benign cutaneous nodules comprised of immature and mature vascular structures intermingled with endothelial cells and a varied infiltrate of eosinophils, histiocytes, lymphocytes, and mast cells.
(12 Dec 1998)
atypical melanocytic hyperplasia Proliferation of melanocytes showing nuclear atypicality, especially as scattered single cells high in the epidermis; interpreted by some pathologists as malignant melanoma in situ.
(05 Mar 2000)
basal cell hyperplasia Increase in the number of cells in an epithelium resembling the basal cells.
(05 Mar 2000)
benign giant lymph node hyperplasia Solitary masses of lymphoid tissue containing concentric perivascular aggregates of lymphocytes, occurring usually in the mediastinum or hilar region of young adults; similar changes have been reported outside the mediastinum and, if associated with interfollicular sheets of plasma cells, may progress to lymphoma or plasmacytoma.
Synonym: angiofollicular mediastinal lymph node hyperplasia, Castleman's disease.
(05 Mar 2000)
benign prostatic hyperplasia <urology> A benign enlargement of the prostate gland begins normally after age 50 years probably secondary to the effects of male hormones. If significant enlargement occurs, it may pinch off te urethra making urination difficult or impossible.
See: urinary retention.
Origin: Gr. Plassein = to form
(06 Aug 1998)
verrucous hyperplasia A non-invasive precursor of verrucous or squamous carcinoma of the oral mucosa, occurring in the elderly, characterised by sharp or blunt upward papillary projections of squamous epithelium.
(05 Mar 2000)
giant lymph node hyperplasia Large benign, hyperplastic lymph nodes. The more common hyaline vascular subtype is characterised by small hyaline vascular follicles and interfollicular capillary proliferations. Plasma cells are often present and represent another subtype with the plasma cells containing IgM and IgA.
(12 Dec 1998)
gingival hyperplasia Non-inflammatory enlargement of the gingivae produced by factors other than local irritation. It is characteristically due to an increase in the number of cells.
(12 Dec 1998)
cementum hyperplasia A regressive change of teeth characterised by excessive development of secondary cementum on the tooth surface. It may occur on any part of the root, but the apical two-thirds are most commonly affected.
(12 Dec 1998)
ÀÌ ¾Æ·¡ ºÎÅÍ´Â °á°ú°¡ ¾ø½À´Ï´Ù.
KMLE ¾àǰ/ÀǾàǰ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • Á¦Ç°¸í
    ¼ººÐ/ÇÔ·®
    ±¸ºÐ/º¸Çè±Þ¿©
KMLE ¾àǰ/ÀǾàǰ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • Á¦Ç°¸í
    ¼ººÐ/ÇÔ·®
    ±¸ºÐ/º¸Çè±Þ¿©
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼­¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼­¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
    ÇÑÀÚ
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
    ÇÑÀÚ
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
´ëÇÑ»ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
´ëÇÑ»ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
KI ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
KI ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
KMLE ÀÇÇоà¾î »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
KMLE ÀÚµ¿ÃßÃâ ÀÇÇоà¾î »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
ÀÇÇÐ³í¹® ¾àÀÚ(Pubmed/Entrez) °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ÄÚµå
    ¿µ¹®
    ÇѱÛ
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ÄÚµå
    ¿µ¹®
    ÇѱÛ
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°­³»°ú ±³½Ç »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
    ¼³¸í
CancerWEB ¿µ¿µ ÀÇÇлçÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
MeSH(Medical Subject Headings) ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú : 0 ÆäÀÌÁö: 3
MeSH(Medical Subject Headings) À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú : 0 ÆäÀÌÁö: 3
¿ÜºÎ ¸µÅ© - Merriam-Webster's ÀÇÇлçÀü ¸ÂÃã °Ë»ö (https://www.merriam-webster.com) °á°ú: 0 ÆäÀÌÁö: 3
¿ÜºÎ ¸µÅ© - Merriam-Webster's ÀÇÇлçÀü À¯»ç °Ë»ö (https://www.merriam-webster.com) °á°ú: 0 ÆäÀÌÁö: 3
¿ÜºÎ ¸µÅ© - A.D.A.M. Medical Encyclopedia ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 3
¿ÜºÎ ¸µÅ© - A.D.A.M. Medical Encyclopedia À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 3
¿ÜºÎ ¸µÅ© - MedlinePlus Health Topics ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 3
¿ÜºÎ ¸µÅ© - MedlinePlus Health Topics À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 3
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ ¸ÂÃã °Ë»ö (http://www.druginfo.co.kr) °á°ú: 0 ÆäÀÌÁö: 3
Á¦Ç°¸í
ÆÇ¸Å»ç
º¸ÇèÄÚµå ¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ À¯»ç °Ë»ö (http://www.druginfo.co.kr) °á°ú: 0 ÆäÀÌÁö: 3
Á¦Ç°¸í
ÆÇ¸Å»ç
º¸ÇèÄÚµå ¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
¿ÜºÎ ¸µÅ© - WebMD.com Drug Reference ¸ÂÃã °Ë»ö (http://www.webmd.com) °á°ú: 0 ÆäÀÌÁö: 3
¿ÜºÎ ¸µÅ© - WebMD.com Drug Reference À¯»ç °Ë»ö (http://www.webmd.com) °á°ú: 0 ÆäÀÌÁö: 3
¿ÜºÎ ¸µÅ© - Drug.com Drugs by Medical Condition ¸ÂÃã °Ë»ö (http://www.drugs.com) °á°ú: 0 ÆäÀÌÁö: 3
¿ÜºÎ ¸µÅ© - Drug.com Drugs by Medical Condition À¯»ç °Ë»ö (http://www.drugs.com) °á°ú: 0 ÆäÀÌÁö: 3
KMLE À¥ ¿ë¾î ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
KMLE À¥ ¿ë¾î À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
ÇÑ¿µ/¿µÇÑ »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
ÇÑ¿µ/¿µÇÑ »çÀü À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
WordNet ÀÏ¹Ý ¿µ¿µ »çÀü °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
¿ÜºÎ ¸µÅ© - American Heritage Dictionary ¿µ¿µ»çÀü ¸ÂÃã °Ë»ö (https://www.ahdictionary.com) °á°ú: 0 ÆäÀÌÁö: 3
¿ÜºÎ ¸µÅ© - American Heritage Dictionary ¿µ¿µ»çÀü À¯»ç °Ë»ö (https://www.ahdictionary.com) °á°ú: 0 ÆäÀÌÁö: 3
ÅëÇÕ°Ë»ö ¿Ï·á